title: Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas.
abstract: BACKGROUND
  Levels of cell-free circulating DNA have been correlated to clinical characteristics and prognosis in patients with cancers of epithelial origin, while there are no data on patients with B-lymphoproliferative diseases.
  
  
  METHODS
  Cell-free DNA levels in the plasma samples of 142 patients with lymphomas [45 with Hodgkin's lymphoma (HL), 63 with diffuse large B-cell non-Hodgkin's lymphoma (DLBCL), 24 with follicular, and 10 with mantle cell non-Hodgkin's lymphoma (NHL)] at diagnosis and of 41 healthy individuals were determined using a quantitative PCR for the beta-globin gene.
  
  
  RESULTS
  Levels of circulating DNA in patients with HL, DLBCL, and mantle cell NHL were significantly higher than in controls (P < 0.01 for all). Increased levels of plasma DNA were associated with advanced stage disease, presence of B-symptoms, elevated lactate dehydrogenase levels, and age >60 years (P = 0.009; <0.0001; <0.0001; 0.04, respectively). In HL, histological signs of necrosis and grade 2 type of nodular sclerosis were associated with increased plasma DNA. Elevated plasma DNA levels were associated with an inferior failure-free survival in patients with HL (P = 0.01) and DLBCL (P = 0.03).
  
  
  CONCLUSIONS
  Quantification of circulating DNA by real-time PCR at diagnosis can identify patients with elevated levels that are associated with disease characteristics indicating aggressive disease and poor prognosis.
authors.affiliation: Istituto di Ematologia e di Anatomia Patologica, Università Cattolica S. Cuore, Rome, Italy. stefan.hohaus@rm.unicatt.it
authors.forename: S
authors.initials: S
authors.lastname: Hohaus
authors.forename: M
authors.initials: M
authors.lastname: Giachelia
authors.forename: G
authors.initials: G
authors.lastname: Massini
authors.forename: G
authors.initials: G
authors.lastname: Mansueto
authors.forename: B
authors.initials: B
authors.lastname: Vannata
authors.forename: V
authors.initials: V
authors.lastname: Bozzoli
authors.forename: M
authors.initials: M
authors.lastname: Criscuolo
authors.forename: F
authors.initials: F
authors.lastname: D'Alò
authors.forename: M
authors.initials: M
authors.lastname: Martini
authors.forename: L M
authors.initials: LM
authors.lastname: Larocca
authors.forename: M T
authors.initials: MT
authors.lastname: Voso
authors.forename: G
authors.initials: G
authors.lastname: Leone
mesh_terms: D000328:Adult; D000368:Aged; D004273:DNA, Neoplasm / Q000097:blood* / Q000235:genetics; D005260:Female; D006689:Hodgkin Disease / Q000097:blood / Q000235:genetics* / Q000473:pathology; D006801:Humans; D016015:Logistic Models; D016403:Lymphoma, Large B-Cell, Diffuse / Q000097:blood / Q000235:genetics* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D016133:Polymerase Chain Reaction; D011379:Prognosis; D055815:Young Adult; D055544:beta-Globins / Q000235:genetics
chemical_list: D004273:DNA, Neoplasm; D055544:beta-Globins